WF-10917

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameWF-10917
Drug Alias NameWF-10917
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationAutoimmune DiseasesPsoriasis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFujisawa Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFujisawa Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAutoimmune DiseasesPsoriasis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A